Sijbrandij Marit, Farooq Saeed, Bryant Richard A, Dawson Katie, Hamdani Syed Usman, Chiumento Anna, Minhas Fareed, Saeed Khalid, Rahman Atif, van Ommeren Mark
Department of Clinical Psychology, VU University Amsterdam and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands.
Post Graduate Medical Institute, Lady Reading Hospital, Peshawar, Pakistan.
BMC Psychiatry. 2015 Oct 1;15:232. doi: 10.1186/s12888-015-0602-y.
In humanitarian settings common mental disorders (depression, anxiety disorders, posttraumatic stress disorder) are highly prevalent. The World Health Organization (WHO) has developed Problem Management Plus (PM+), a 5-session, individual psychological intervention program, delivered by paraprofessionals that addresses common mental disorders in people in communities affected by adversity. The objectives of this study are to test effectiveness and cost-effectiveness of the locally adapted PM+ compared to Treatment as usual (TAU) in Peshawar District, Pakistan.
A randomised controlled trial will be conducted in 346 primary care attendees in 3 health care centres in Peshawar District, Pakistan. After informed consent, primary care attendees with high levels of psychological distress according to the General Health Questionnaire-12 (GHQ-12) and functional impairment (WHO Disability Assessment Schedule 2.0 (WHODAS)) will be assigned to PM+ (n = 173) or TAU (n = 173). At baseline, 1 week and 3 months following PM+, independent assessors will assess psychological distress with the Hospital Anxiety and Depression Scale (HADS), and functional disability with the WHODAS. Secondary outcomes are posttraumatic stress disorder (PTSD) symptoms, and client-perceived priority problems. Further, cost-effectiveness will be assessed using the Service Receipt Inventory (SRI).
If proven effective, PM+ will be rolled out to other areas for further adaptation and testing in diverse humanitarian settings.
ACTRN12614001235695. Registered 26 November 2014. Australian New Zealand Clinical Trials Registry.
在人道主义环境中,常见精神障碍(抑郁症、焦虑症、创伤后应激障碍)极为普遍。世界卫生组织(WHO)开发了问题管理强化版(PM+),这是一个由非专业人员实施的、为期5节的个体心理干预项目,旨在解决受逆境影响社区人群的常见精神障碍。本研究的目的是在巴基斯坦白沙瓦地区,将本地化的PM+与常规治疗(TAU)进行比较,测试其有效性和成本效益。
将在巴基斯坦白沙瓦地区3个医疗中心的346名初级保健就诊者中进行一项随机对照试验。在获得知情同意后,根据一般健康问卷-12(GHQ-12)和功能损害(世界卫生组织残疾评估量表2.0(WHODAS)),将心理困扰程度较高的初级保健就诊者分配至PM+组(n = 173)或TAU组(n = 173)。在基线、PM+实施后1周和3个月时,独立评估人员将使用医院焦虑抑郁量表(HADS)评估心理困扰程度,并使用WHODAS评估功能残疾情况。次要结局为创伤后应激障碍(PTSD)症状以及患者感知的首要问题。此外,将使用服务收据清单(SRI)评估成本效益。
如果经证实有效,PM+将推广至其他地区,以便在不同的人道主义环境中进行进一步调整和测试。
ACTRN12614001235695。于2014年11月26日注册。澳大利亚新西兰临床试验注册中心。